Jeffrey Humphrey - 01 Oct 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)

Role
Chief Medical Officer
Signature
/s/ Thomas W. Beetham, Attorney-in-Fact for Jeffrey Humphrey
Issuer symbol
DNTH
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
04 Oct 2021, 16:34:18 UTC
Previous filing
19 Jul 2021
Next filing
16 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +275,000 $0.000000 275,000 01 Oct 2021 Common Stock 275,000 $7.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exerciseable over four years, with 25% of this option vesting on October 1, 2022, and the remainder vesting in 36 equal monthly installments thereafter.